-
Revenues: US $ 1.20 billion (an increase of 23% compared to FY 2024).
-
Net income: US $ 69.8 million (a loss of US $ 6.10 million in FY 2024).
-
Profit margin: 5.8% (an increase in net loss in FY 2024).
-
EPS: US $ 0.83 (a loss of US $ 0.074 in FY 2024).
AI is about to change healthcare. These 20 shares work on everything, from early diagnostics to drug discovery. The best part – they are all less than $ 10 billion in MarketCap – there is still time to come in early.
All figures shown in the graph above are for the 12 -month period (TTM)
The turnover exceeded the estimates of the analysts by 1.5%. The profit per share (EPS) also exceeded estimates of analysts by 100%.
In the past 12 months, the only income segment was software and programming that US $ 1.20 billion contributed. The largest operating costs were the costs for research and development (R&D), for an amount of US $ 296.2 million (42% of the total costs). In the past 12 months, the company’s income was reinforced by non-operational profits of US $ 28.7 million. Investigate how GWRE’s income and expenditure forms its income.
Looking ahead, the turnover will grow on average by 12% PA over the next 3 years compared to a 13% growth spelling for the software industry in the US.
Implementation of the American software industry.
The shares of the company have risen by 20% compared to a week ago.
However, it is worth noting that we have found 2 Warning signals for guidewire software What you have to take into account.
Feedback on this article? Worried about the content? Contact us With us immediately. As an alternative e-mail editorial team (AT) Easlewallst.com.
This article by Simply Wall St is generally in nature. We comment based on historical data and analyst forecasts that only use an unbiased methodology and our articles are not intended as financial advice. It is not a recommendation to buy or sell shares and does not take your objectives or your financial situation into account. We strive to bring you in the long term -targeted analysis, powered by fundamental data. Note that our analysis may not take into account the latest price -sensitive company announcements or qualitative material. Simply Wall St has no position in the aforementioned stocks.
